Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: OLIFANT MEDICAL, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-03-01 to 2025-06-30
Current total value of award: $1093651.76
Description: AWARD OF OLIFANT'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "REVISITING THE NASOPHARYNGEAL AIRWAY (NPA): THE NEXT-LEVEL NPA"